SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-15-016259
Filing Date
2015-04-23
Accepted
2015-04-23 17:00:32
Documents
1
Period of Report
2015-04-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 7288
  Complete submission text file 0001140361-15-016259.txt   8678
Mailing Address C/O PDL BIOPHARMA, INC. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451
Business Address
MCLAUGHLIN JOHN PETER (Reporting) CIK: 0001277967 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 15789130

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269
Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)